Published

2024 - politicians from all sides ask the government to prevent the sale of the Sanofi subsidiary to an American fund

Summary by The Latest News
A box of Doliprane in a pharmacy in Colomiers, in the southwest of France, March 23, 2023. VALENTINE CHAPUIS / AFP From both left and right, parliamentarians from several political parties urged the government on Friday October 10 to block the sale of Opella, a Sanofi subsidiary responsible in particular for the manufacture of Doliprane. Doliprane, the best-selling drug in France, is about to pass under the American flag, Sanofi having announc…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.